M. Sasaki et al., Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: Searching for a mimic, J AUTOIMMUN, 15(1), 2000, pp. 51-60
Previous studies documenting the existence of cross-reactivity between the
lipoated (but not unlipoated) forms of the inner lipoyl domain (E2L2) of PD
C-E2 [the major autoantigen in Primary biliary cirrhosis (PBC)] and trifluo
roacetylated (TFA) proteins, led us to hypothesize that PBC may be due to a
n initial insult with an environmental agent that cross-reacts with TFA. Th
erefore, we performed a comparative study of the reactivity of rabbit anti-
TFA antibody and anti-lipoic acid (LA) antibody against the mitochondrial a
utoantigens of human PBC and various TFA and LA conjugated proteins. Wherea
s both anti-TFA and anti-LA reacted with PDC-E2, the wild-type lipoated for
m of E2L2, OGDC-E2 E3-BP and LA-KLH, neither reacted with BCOADC-E2 or the
non-lipoated form of E2L2. Of interest was that while anti-TFA reacted with
PDC-E2, TFA-RSA and LA-KLH, it failed to inhibit PDC-E2 enzyme function. I
n contrast, anti-LA demonstrated cytoplasmic and mitochondrial staining, an
d inhibited PDC enzyme activity. Hence, although considerable cross reactiv
ity exists between anti-TFA and anti-LA, the molecular nature of the intera
ction is clearly different. One of 14 PBC sera reacted weakly with TPA-albu
min, whereas four of 14 PBC sera reacted with LA-KLH. Immunohistochemically
, both anti-TFA and anti-LA antibodies reacted focally with periportal hepa
tocytes and bile ducts in both PBC and controls. However, anti-LA produced
much stronger focalized staining of the bile ducts of diseased liver. This
study suggests that while anti-TFA antibody recognizes lipoic acid-linked e
nzymes and proteins, the epitope recognized differs from that of anti-LA an
tibody and PBC autoantibodies. It is unlikely that a response to TFA is the
triggering event in PBC. Anti-LA antibodies share a higher degree of simil
arity to PBC sera providing suggestive evidence that anti-LA antibodies or
anti-LA like antibodies (mimotopes) may help define the initiator of the au
toimmune response. (C) 2000 Academic Press.